Being a responsible citizen

Why is it important?
Society increasingly expects companies to take a stand on global challenges such as poverty, social justice, climate change and other complex issues, which the COVID-19 pandemic has brought into even sharper focus. Our purpose as a global medicines company is inherently social, and we have a responsibility, together with governments and civil society, to contribute solutions to big societal problems. We can help drive positive change by harnessing the assets that make us successful in the first place: people, ideas and capital.
Our targets
Environment targets
Become carbon neutral in our own operations (Scope 1 and 2) and include environmental criteria in all supplier contracts by 2025.
Achieve full carbon neutrality across the value chain (Scope 1, 2, and 3) by 2030
Reduce water consumption in our operations by half by 2025 (vs. 2016), with no water quality impacts from the manufacturing of our products
Be water neutral in all areas of our operations by 2030 while enhancing water quality wherever we operate
Eliminate polyvinyl chloride in packaging (secondary and tertiary packaging; primary packaging when feasible) by 2025
Reduce the amount of waste sent for disposal by half by 2025 (vs. 2016)
Be plastic neutral by 2030, with all new products meeting sustainable design principles
Diversity and inclusion
Achieve gender balance in management by 2023
Close the gender pay gap by 2023
Training and development
Invest USD 100 million in learning over five years from 2019
Our approach and performance
Novartis is committed to playing a positive and constructive role in society. We are focused on building a company that our patients, customers, associates, shareholders and partners can all be proud of. Above all, we aim to discover and develop breakthrough treatments that improve and extend people’s lives, and to deliver them to as many people as possible. Our primary concern is to protect the safety and well-being of everyone who uses our medicines. We engage with patients and caregivers worldwide to help ensure their needs and concerns are reflected in our clinical research and business operations. The health and safety of our associates are also key. As COVID-19 spread globally in 2020, we regularly assessed the situation and adapted accordingly to help ensure the well-being of those working remotely and those who needed to be on our premises. We want to be a responsible citizen wherever we do business, and we aim to minimize our environmental impact around the world.
In this section
Read about our efforts to protect the safety of those using our medicines, care for our people, and minimize our impact on the environment: